Search Browse Earnings

Coeptis Therapeutics Holdings, Inc.

Nasdaq:COEPNasdaq:COEPW

Finance Services·WEXFORD, PA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Coeptis Therapeutics Holdings, Inc. — SlamSEC

Revenue

$0

FY 2024

Adj. EBITDA

-$20.5M

FY 2024

Net Income

-$21.3M

FY 2024

EPS (Diluted)

-$16.56

FY 2024

Stock Price

$13.04

+5.6%

2026-03-06

52W Range

$6.26 – $21.41

P/E Ratio

-0.8x

Market Cap

$69.6M

Cash

$907,184

FY 2021

Total Debt

$2.0M

FY 2023

Net Debt

$1.1M

FY 2023

Enterprise Value

$70.7M

Debt / EBITDA

-0.1x

FY 2024

EV / EBITDA

-3.5x

Employees

—

CEO

Mehalick David

CFO

Cogley Brian